Association of Abnormal Cardiac Biomarkers and Cardiovascular Complications, with Mortality in Patients with SARS-CoV-2 Infection in Latin America.
Juan Esteban Gomez-MesaManuela EscalanteJuan Andrés Muñoz-OrdoñezValeria Azcárate-RodriguezJuan David Peláez-MartínezAndrea Alejandra Arteaga-TobarHoover O León-GiraldoAndrea Valencia-OrozcoEduardo Roque PernaAlexander RomeroIván MendozaFernando Stuardo Wyss QuintanaJosé Luis BarisaniMario Osvaldo Speranza-SanchezWalter Alberto Alarco LeónCesar HerreraJulián Lugo-PeñaLiliana Patricia Cárdenas-AldazVíctor Alejandro Rossel-MariángelDaniel Sierranull nullPublished in: Journal of cardiovascular development and disease (2024)
In Latin American COVID-19 patients, a higher number of positive cardiac biomarkers is associated with increased cardiovascular complications and mortality. These findings suggest that cardiac biomarkers should be utilized to guide acute-phase treatment strategies.